EcoDrugPlus

Cathepsin C

Ensembl ID : ENSKMAG00000007894
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSKMAG00000017740
Gene Symbol: LOC108243181
3 Cross references
222 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSKMAG00000017771
Gene Symbol: LOC108243190
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSKMAG00000002260
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSKMAG00000022245
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSKMAG00000019006
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSKMAG00000021943
Gene Symbol: CCKBR
3 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSKMAG00000007424
Gene Symbol: LOC108248694
2 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSKMAG00000002848
Gene Symbol: LOC108231838
2 Cross references
254 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSKMAG00000002756
Gene Symbol: LOC108231837
2 Cross references
254 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSKMAG00000002988
Gene Symbol: LOC108231774
2 Cross references
254 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSKMAG00000002415
Gene Symbol: LOC112450290
2 Cross references
254 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).